Disease activity at the first visit to the clinic by TPA category
| No plaques N=90 | Mild atherosclerosis N=39 | Moderate atherosclerosis N=65 | Severe atherosclerosis N=41 | p Value | |
|---|---|---|---|---|---|
| Tender joint count | 7.8±9.1 | 7.1±7.7 | 8.0±9.3 | 6.5±7.1 | 0.56 |
| Swollen joint count | 4.1±5.5 | 2.8±3.2 | 4.3±6.4 | 3.2±3.5 | 0.70 |
| PASI | 4.5±6.2 | 2.5±2.4 | 5.4±7.3 | 7.5±13.4 | 0.51 |
| Damaged joint count | 2.4±5.9 | 4.3±9.3 | 2.6±5.4 | 4.2±9 | 0.38 |
| ESR (mm/h) | 16.7±15.1 | 21.2±17.1 | 24.3±18.3 | 23.5±21.9 | 0.03 |
| CRP (mg/dL) | 10.1±9.96 | 6.7±8.2 | 16.2±23.4 | 6.9±6.6 | 0.99 |
| WBC count(109/L) | 7.2±1.9 | 7.3±1.9 | 7.6±2.2 | 7.9±2.2 | 0.05 |
| DAPSA | 18.4±11.6 | 21.6±11.2 | 19.2±8.8 | 19.9±11.7 | 0.75 |
| PASDAS | 4.1±0.9 | 3.8±0.7 | 4.3±0.7 | 4.6±0.6 | <0.001 |
| HAQ | 0.7±0.7 | 0.7±0.6 | 0.7±0.6 | 1±0.7 | 0.16 |
Bold type indicates a significant association (p<0.05).
CRP, C-reactive protein; DAPSA, Disease Activity index for Psoriatic Arthritis; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; PASDAS, Psoriatic Arthritis Disease Activity; PASI, Psoriasis Activity and Severity Index; TPA, total plaque area; WBC, white blood cell.